$CURLF Balance Sheet | Understand Stock

$CURLF

$9.92 +$0.45 (4.75%) Close

$CURLF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020
Cash and cash equivalents
Accounts receivable, net
Inventories, net
Biological assets
Assets held for sale
Prepaid expenses and other current assets
Current portion of notes receivable
Total current assets
Deferred tax asset
Notes receivable
Property, plant and equipment, net
Right-of-use assets, net
Intangible assets, net
Goodwill
Investments
Prepaid acquisition consideration
Other assets
Total assets
Accounts payable
Accrued expenses
Income tax payable
Current portion of lease liability
Current portion of notes payable
Current contingent consideration liability
Liabilities held for sale
Other current liabilities
Total current liabilities
Deferred tax liability
Notes payable
Lease liability
Non-controlling interest redemption liability
Contingent consideration liability
Other long term liability
Total liabilities
Share capital
Treasury shares
Reserves
Accumulated other comprehensive income.
Accumulated deficit
Redeemable non-controlling interest contingency
Total Curaleaf Holdings, Inc. shareholders' equity
Non-controlling interest
Total shareholders' equity
Assets
Current assets:
Cash and cash equivalents (including restricted cash and cash equivalents)
Accounts receivable, net of allowance for credit losses of $6,717 and $4,042, respectively
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $1,982 and $2,617, respectively
Inventories
Assets held for sale
Assets held for sale and discontinued operations
Prepaid expenses and other current assets
Notes receivable - current
Total current assets
Deferred tax asset
Income tax receivable
Investments and other assets
Other assets - net of current
Notes receivable - net of current
Property, plant and equipment, net
Right-of-use assets, finance lease, net
Right-of-use assets, operating lease, net
Intangible assets, net
Goodwill
Investments
Total assets
Liabilities, Temporary equity and Shareholders’ equity
Current liabilities:
Accounts payable
Accrued expenses
Income tax payable
Lease liabilities, finance - current
Lease liabilities, operating - current
Notes payable - current
Contingent consideration liability - current
Deferred consideration liability - current
Financial obligations - current
Liabilities held for sale
Liabilities associated with assets held for sale and discontinued operations
Other current liabilities
Total current liabilities
Deferred tax liability
Notes payable - net of current
Lease liabilities, finance - net of current
Lease liabilities, operating - net of current
Uncertain tax position
Contingent consideration liability - net of current
Deferred consideration liability - net of current
Financial obligations - net of current
Other non-current liabilities
Total liabilities
Temporary equity:
Redeemable non-controlling interest contingency
Shareholders’ equity:
Common stock, no par value; unlimited shares authorized; 264,737,501 and 257,491,582 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Treasury shares
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Total liabilities, temporary equity and shareholders’ equity

Comments